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Abstract
Background: In England, prostate cancer patients report worse experience of care than patients
with other cancers. However, no standard measure of patient experience of prostate cancer care
is currently available. This paper describes an evaluation of the reliability, validity and acceptability
of the PCQ-P, a newly developed instrument designed to measure patient experience of prostate
cancer care.
Methods: The reliability, acceptability and validity of the PCQ-P were tested through a postal
survey and interviews with patients. The PCQ-P was posted to 1087 prostate cancer patients
varying in age, occupation, and overall health status, sampled from five hospitals in England.
Nonresponders received one reminder. To assess criterion validity, 935 patients were also sent
sections of the National Centre for Social Research Shortened Questionnaire; and to assess test-
retest reliability, 296 patients who responded to the questionnaire were resent it a second time
three weeks later. A subsample of 20 prostate cancer patients from one hospital took part in
qualitative interviews to assess validity and acceptability of the PCQ-P. Acceptability to service
providers was evaluated based on four hospitals' experiences of running a survey using the PCQ-P.
Results: Questionnaires were returned by 865 patients (69.2%). Missing data was low across the
sections, with the proportion of patients completing less than 50% of each section ranging from
4.5% to 6.9%. Across the sections of the questionnaire, internal consistency was moderate to high
(Cronbach's alpha ranging from 0.63 to 0.80), and test-retest stability was acceptable (intraclass
correlation coefficients ranging from 0.57 to 0.73). Findings on criterion validity were significant.
Patient interviews indicated that the PCQ-P had high face validity and acceptability. Feedback from
hospitals indicated that they found the questionnaire useful, and highlighted important
considerations for its future use as part of quality improvement initiatives.
Conclusion: The PCQ-P has been found to be acceptable to patients and service providers, and
is ready for use for the measurement of patient experience in routine practice, service
improvement programmes, and research.
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Background
In this paper we report the reliability and validity of a
questionnaire to measure the experience of prostate can-
cer care. We also report the acceptability of the question-
naire to patients and to hospitals providing care for
patients with prostate cancer.
In England, patients with prostate cancer report worse
experience of care than patients with other cancers [1,2],
and the provision of readily usable measures was one ele-
ment of a wider initiative designed to improve services
[3,4]. While care outcomes can be assessed through stand-
ard measures of health-related quality of life [5], which
include reports of general health and impact on function-
ing, no standard measures of patient experience of the
process and delivery of prostate cancer care are available
[6]. In recent years, patient surveys have tended to focus
on patient experience of care rather than on satisfaction
with care. Satisfaction is a complex concept incorporating
patients' expectations, their experience of what happened
in care, their feelings about the care they received, and the
importance to the patient of the aspect of care concerned.
Measures of patients' experience - which comprise
patients' reports of what happened in specific aspects of
the delivery of care - are simpler to interpret and act upon
than measures of satisfaction [7]. Surveys of experience
are now generally preferred by providers, and considered
helpful in evaluating and improving services.
In the wake of the NHS next stage review, all NHS organ-
isations will be required to gather and publish informa-
tion about patient experience of care, as part of a process
of working towards high quality of care for all [8]. The
availability of valid and acceptable measures of patient
experience is crucial to ensuring that meaningful data are
collected. To be suitable for wide use, measures of experi-
ence need to be developed systematically to address the
issues that are important to patients, to be readily under-
stood and acceptable by patients, and to meet standards
of reliability and validity. They should also be acceptable
to providers, enabling them to assess specific stages of
care, depending on the provider's focus for quality
improvement. Our aim was to develop a robust and
acceptable measure suitable for use in routine practice
and research. This paper describes such a measure of
patient experience of prostate cancer care - the Prostate
Care Questionnaire for Patients (PCQ-P) - and reports on
the formal evaluation of the measure's reliability, validity
and acceptability to patients and service providers. A com-
panion measure for use with carers of men with prostate
cancer has also been developed [9].
Methods
Development and characteristics of the PCQ-P
The PCQ-P is a measure developed from preliminary
research designed to determine the issues most important
to prostate cancer patients, including a literature review of
the experiences of patients of prostate cancer care, and
interviews with patients and service providers [10-12].
Key issues included: information and explanations,
involvement in decision making, provision of advice and
support, delays in care, choice, coordination of care, and
practical issues (such as travel, and facilities at the hospi-
tal). Questions on these issues were developed, phrased in
the words used by patients. Thorough piloting was under-
taken [10]. The measure, along with a user guide, is avail-
able online for download and use [13]. The questionnaire
is divided into five sections: GP visits and referral (Section
A, 17 questions); tests at the hospital (Section B, 19 ques-
tions); diagnosis and treatment decision (Section C, 30
questions); treatment and discharge (Section D, 25 ques-
tions); and monitoring (Section E, 15 questions). There is
a sixth section to collect health and sociodemographic
information (Section F, 10 questions). Sections can be
administered separately, or in appropriate combinations
(e.g. it may be useful to give sections A, B, and C in com-
bination to patients who have recently received a diagno-
sis of prostate cancer). A short version of the
questionnaire, comprising 24 questions chosen to include
the most important issues to patients, is also available
[10,13].
Sampling
Five hospitals in England were selected to participate in
the study to test reliability, validity and acceptability to
patients. Hospitals represented a range in terms of urban
and rural locality, teaching and non-teaching hospitals,
and foundation trust status (Table 1). Each hospital drew
a consecutive sample of all patients who had been diag-
nosed with, or treated for, prostate cancer within the past
two years, excluding patients who had died or were too ill
to participate; this produced a list of between 152 and 253
patients per hospital depending on the numbers of
patients with prostate cancer under their care. The sample
included patients at different stages of care (e.g. undergo-
ing treatment, undergoing post-treatment monitoring). A
total of 1087 patients were identified. Hospital staff
mailed sections of the PCQ-P to patients, and non-
responders were sent one reminder. Sections A, B, C, and
F in combination were sent to 431 patients (in hospitals 1
and 3), and Sections D, E and F to 504 patients (in hospi-
tals 2 and 4). One hundred and fifty two patients (in hos-
pital 5) received all 5 sections in combination.
Measures of reliability, validity and acceptability to 
patients
To assess criterion validity, 935 patients (in hospitals 1 to
4) were also sent sections of the National Centre for Social
Research Shortened Questionnaire (NCSRSQ), a ques-
tionnaire designed to measure patients' experience of care
for several different forms of cancer [14]. To assess test-
retest reliability, 296 patients from two hospital sitesBMC Health Services Research 2009, 9:199 http://www.biomedcentral.com/1472-6963/9/199
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(hospitals 1 and 2) were posted the PCQ-P questionnaire
again three weeks later.
In addition, 20 patients from hospital 5, who had com-
pleted all sections of the PCQ-P, took part in semi-struc-
tured interviews to explore acceptability and face validity.
Eleven face-toface and nine telephone interviews were car-
ried out. Interviews were not transcribed, but notes were
taken by the interviewer during the interview.
Key properties of the questionnaire sections, including
aspects of validity, reliability, and acceptability to patients
were analysed. For the purpose of testing the properties of
the questionnaire, overall scores were calculated for each
section of the questionnaire, by summing scores across
questions and converting to a score out of 100, with
higher scores indicating more positive experiences of care
[10]. All statistical analyses were conducted using SPSS
version 16.0.
Acceptability to patients
Acceptability was evaluated by examining completion
rates for individual questions and questionnaire sections,
and by analysing distributions of responses for individual
questions. Acceptability was also assessed in patient inter-
views, by asking patients how they felt about the experi-
ence of completing the questionnaire.
Validity
Criterion validity was assessed by examining Pearson cor-
relations between scores on sections B to E of the PCQ-P
and the NCSRSQ. The NCSRSQ did not contain compara-
ble questions for section A of the PCQ-P. The NCSRSQ is
a measure of problems in care, where in contrast to the
PCQ-P a higher score indicates a less positive experience
of care, therefore a negative correlation between the scores
on the two questionnaires was expected. The NCSRQ is a
generic questionnaire rather than being specific to pros-
tate cancer, and a medium-sized correlation co-efficient (-
0.3 to -0.5) was expected as an indicator of validity
[15,16]. Face validity was investigated through patient
interviews, in which patients were asked to describe their
experiences of care in conjunction with inspection of their
responses to the questionnaire, as well as being asked
directly whether there were any important aspects of care
that were not included in the questionnaire. Content
validity was assessed through comparing the results of
exploratory principal components analysis (PCA) with
themes identified through the preliminary research
[11,12].
Reliability
Internal consistency reliability for each section was meas-
ured using Cronbach's alpha [17]. Stability reliability was
assessed using intraclass correlation coefficients (ICCs)
between scores on the first and second completion of the
questionnaire. Stability was also assessed by calculating
the percentages of patients answering each question the
same way on the first and second completion of the ques-
tionnaire.
Usability and acceptability to service providers
The usability and acceptability of the questionnaire to
service providers was assessed through inviting a separate
sample of hospitals to coordinate and run a patient expe-
rience survey using the PCQ-P, then seeking feedback on
their experiences of this process. Hospitals were recruited
via Service Improvement Leads (SILs) at the Cancer Net-
works, who identified hospitals within their network that
would be willing to take part in this stage of the study.
Four hospitals in England were selected from the list of
identified hospitals, selected to ensure a range in terms of
urban and rural locality, teaching and non-teaching hos-
pitals, and foundation trust status. The characteristics of
the four hospitals which took part in this separate stage of
acceptability testing are given in Table 2. Hospitals were
provided with questionnaires, a user guide developed as
part of the study [13], and software to enable them to
enter their data and produce basic summary results. Three
hospitals each used a different selection of sections of the
full measure, and one hospital used the short version of
the questionnaire covering the whole patient journey.
Hospitals were asked to survey around 100 patients, and
feedback on their experiences was gained through semi-
structured interviews with one or two key persons who
had administered the survey in each hospital (total of 5
Table 1: Features of hospitals: testing the questionnaire for reliability, validity, and acceptability to patients
Hospital 1 Hospital 2 Hospital 3 Hospital 4 Hospital 5
Foundation Trust No No No Yes Yes
Teaching Hospital No No Yes Yes Yes
Population served Urban Rural Urban Urban Rural
Location in England South South West South West London East AngliaBMC Health Services Research 2009, 9:199 http://www.biomedcentral.com/1472-6963/9/199
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interviews), along with informal discussion with other
members of hospital staff. Interviews were not tran-
scribed, but notes were taken by the interviewer during
the interview.
Results
Acceptability to patients
Questionnaires were returned by 865 patients (69.2%);
355 completed Sections A, B, C and F (response rate:
61%), and 510 completed Sections D, E and F (response
rate: 77.7%). This response rate is similar to that achieved
for prostate cancer patients in the National Survey of NHS
Cancer Patients in 1999/2000 [18]. The demographic
characteristics and health status of responders are summa-
rised in Table 3.
The proportion of patients completing fewer than 50% of
the questions in each section was low: 16 patients (4.5%)
for Section A, 20 (5.6%) for Section B, 18 (5.1%) for Sec-
tion C, 30 (5.9%) for Section D, and 35 (6.9%) for Section
E. Missing data were usually due to patients omitting
whole sections, sometimes appropriately (e.g. no medical
tests at the named hospital) but without making the rea-
sons clear. For patients who completed more than 50% of
the questionnaire, missing data for individual questions
ranged from 0% to 15.4%, the majority showing less than
10% missing data. Responses to most questions were well
distributed across response options. Overall, patients
more often reported positive experiences, with mean over-
all scores ranging from 65.9 to 86.4 across the sections.
Descriptive statistics of section scores are shown in
Table 4.
In the patient interviews, patients described the questions
as easy to understand, and the majority did not report any
problems with filling in the questionnaire. One patient
commented that his case did not fit well with the
sequence of sections as they were presented in the full
questionnaire (compiled from all five subsections), and
two patients felt that the full questionnaire was too long.
Three patients emphasised that each section should be
administered as soon as possible after the relevant phase
of treatment or care, as they found it difficult to remember
in detail events from several months previously. Patients
suggested that the sections should be divided and used as
separate questionnaires, or with just two to three sections
in combination, with appropriate sections being adminis-
tered as soon as possible after the relevant stage of care.
Criterion validity
Out of 935 patients, 592 (63.3%) completed both a PCQ-
P and a NCSR questionnaire. Response rates were 224/
431 (52%) for Sections A, B, C, and F, and 368/504 (73%)
for Sections D, E, and F. Pearson's correlation coefficient
between Sections B and C and the first half NCSRSQ was
-0.23 (p = 0.002, N = 175), and between Sections D and E
and the second half NCSRSQ was -0.46 (p < 0.001, N =
201). These correlations are in the expected direction, the
first is small and the second is medium [15,16], and both
are significant at p < 0.005.
Face and content validity
All interview participants indicated that the question-
naires covered important aspects of care. However, several
patients highlighted gaps in the section on discharge. The
particular issues identified as important were: knowing
what to expect in terms of recovery time and side effects;
and knowing how to obtain appropriate supplies after dis-
charge (such as continence pads). This led to two ques-
tions on these issues being added to the questionnaire.
Content validity was assessed through exploratory princi-
pal components analysis. Analysis identified three to four
components for each section of the questionnaire (see
additional file 1: exploratory PCA). For example in section
A (GP visits and referral), three components emerged, and
inspection of questions within each component suggested
that the components related to: 'explanation', 'taking the
problem seriously' and 'experience of referral'. Compari-
son of these components with themes from the initial
patient interviews and literature review [11,12] confirmed
that the key aspects of care identified in the preliminary
research were satisfactorily incorporated in the PCQ-P.
Internal consistency reliability
Cronbach's alpha coefficients ranged from 0.63 to 0.80,
indicating moderate to high internal consistency for all
sections of the PCQ-P (Table 5).
Table 2: Features of hospitals: testing the questionnaire for usability and acceptability to service providers
Hospital A Hospital B Hospital C Hospital D
Foundation Trust Yes Yes No No
Teaching Hospital Yes No No Yes
Population served Urban Rural Rural Urban
Location in England London South West Midlands MidlandsBMC Health Services Research 2009, 9:199 http://www.biomedcentral.com/1472-6963/9/199
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Test-retest reliability
Out of 296 patients, 148 (50%) completed the retest ques-
tionnaire; 79/125 (63.2%) completed Sections A, B, C,
and F, and 69/171 (40.4%) completed Sections D, E, and
F. Patients completing retest questionnaires did not differ
significantly from other patients in terms of age, health
status, ethnic group, or employment status (p > 0.05 in
each case). The test-retest ICCs for the five sections were
between 0.57 and 0.73, and all were significant at p <
0.001 (Table 5), indicating acceptable reliability [19]. The
consistency of responses to individual questions was high,
between 52.6% and 100% of patients answering identi-
cally on the first and second mailing. Most questions (94,
88.7%), were answered perfectly consistently by over 70%
of responders. The questions where responses were less
consistent were those with a higher number of response
options, and for these questions the difference between
responses on the first and second completion of the ques-
tionnaire tended to be a shift to the neighbouring
response option, for example, from 'good' to 'very good'.
Acceptability to service providers
Three of the four participating hospitals chose to admin-
ister the questionnaire by post, and one used a combina-
tion of postal administration and face-to-face
administration in urology clinics. None of the hospitals
reported major difficulties with running the survey. How-
ever, the administration of the survey was seen as time
consuming, and hospitals found this problematic; one
hospital in particular had difficulty finding staff with time
available to run the survey. Hospitals felt that the provi-
sion of support to run the survey would be helpful, and
one hospital suggested that administering the survey pro-
spectively to patients over a longer period of time would
be more manageable and would produce valuable data.
Agreement to conduct the survey had initially been
obtained from a consultant in each hospital, and some
staff felt that an essential first stage would be a meeting
involving all staff who would have a role in the adminis-
tration of the survey. This would promote ownership of
the survey, ensure local support, and provide a setting
where input of time could be negotiated. There were
mixed feelings about the involvement of an external
organisation to coordinate the survey, possibly on a
national basis; staff described a preference for using sur-
veys as part of their own internal quality improvement
process, and were resistant to the idea of surveys being
used as an "external stick" (Hospital B) to raise perform-
ance, or being linked to financial incentives.
Hospital staff feedback indicated that they found the
questionnaire relevant and would value it as a tool for
their own use, particularly if benchmarks or comparative
data were available from other hospitals. Staff were partic-
ularly keen to have access to comparative data for local
hospitals, as they felt this would have the greatest impact
on efforts to improve quality - they "like to do better than
others locally!" (Hospital A). It is possible to present com-
Table 3: Demographic characteristics and overall health status of 
patient sample: reliability and validity testing
Age (years) N (%)i
< 54 18 (2.1)
55-64 215 (24.9)
65-74 350 (40.5)
75+ 262 (30.3)
Overall health
Very good 253 (29.2)
Good 385 (44.5)
Fair 166 (19.2)
Poor 28 (3.2)
Very poor 10 (1.2)
Ethnicity
White British/Irish 803 (92.8)
South Asian 10 (1.2)
African/Caribbean 17 (2.0)
Other 2 (0.2)
Current situation
Employed 185 (21.3)
Retired 624 (72.1)
Other 24 (2.8)
Current or most recent occupation
Professional 239 (27.6)
Managerial 178 (20.6)
Clerical 35 (4.0)
Technical/craft 148 (17.1)
Manual/service 136 (15.7)
iMay not add to 100 due to missing dataBMC Health Services Research 2009, 9:199 http://www.biomedcentral.com/1472-6963/9/199
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parative data on the PCQ-P at the level of whole sections,
components within sections, and individual questions,
using bar charts (Figure 1 illustrates this with data from
three of the hospitals involved in reliability and validity
testing). Although further work is required to establish the
components within each section, the PCQ-P shows poten-
tial to produce data across a range of levels of detail that
may be useful in interpreting their results. For example,
inspecting results at the level of section and component
scores allows a hospital to identify areas where they may
be performing less well than other hospitals, then inspect-
ing specific question results within a component can help
pinpoint specific areas of care which may be problematic.
Discussion
The evaluation of the PCQ-P demonstrates that the instru-
ment incorporates issues that are important to prostate
cancer patients, has good reliability and validity, and is
acceptable to patients and service providers. The PCQ-P
can be used flexibly - single sections can be used inde-
pendently or in combination with other relevant sections,
and a short version [10] covering the whole patient jour-
ney is also available.
Some limitations should be noted. The evaluation of cri-
terion validity was hampered by the absence of any satis-
factory criterion. No other suitable measure of patient
experience of prostate cancer care was available, hence a
Table 4: Descriptive statistics of overall scores from the five sections of the questionnaire
Sectioni N Mean
score
SD Minimum Maximum % with lowest possible score % with highest possible score
Section A 307 65.9 21.1 .00 100.0 0.7 5.1
Section B 328 82.3 14.0 28.5 100.0 0.0 3.9
Section C 292 86.4 13.4 27.8 100.0 0.0 17.5
Section D 304 71.0 16.2 16.2 100.0 0.0 1.2
Section E 459 71.3 20.8 .00 100.0 0.4 12.0
iSection A = GP visits and referral, Section B = tests at the hospital, Section C = diagnosis and treatment decision, Section D = treatment and 
discharge, Section E = monitoring
Table 5: Reliability: Internal consistency and stability of the five sections of the PCQ-P
Internal consistency Stability: Test-retest reliability
Sectioni Cronbach's α 1st mailing mean
score
SD, min-max
(N)
2nd mailing mean
score
SD, min-max
(N)
Intraclass
Correlation
Coefficient
(ICC)
Section A 0.80 69.1 68.5 0.68
19.6, 11.5-100 (60) 18.7, 16.7-100 (62)
Section B 0.63 84.4 81.3 0.57
15.3, 28.5-100 (73) 10.6, 39.7-99.4 (72)
Section C 0.77 88.4 87.6 0.61
12.0, 55.0-100 (62) 13.1,31.3-100 (63)
Section D 0.80 73.2 74.8 0.73
17.1, 27.7-99.23 14.5, 41.4-100 (49)
(48)
Section E 0.68 74.3 74.9 0.70
21.9, 16.7-100 (61) 19.7, 18.8-100 (60)
iSection A = GP visits and referral, Section B = tests at the hospital, Section C = diagnosis and treatment decision, Section D = treatment and 
discharge, Section E = monitoringBMC Health Services Research 2009, 9:199 http://www.biomedcentral.com/1472-6963/9/199
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generic patient experience questionnaire (NCSRSQ) was
used as an indicative criterion. Nevertheless, the findings
of the criterion validity check show small to medium
sized, but significant, correlations between scores on the
PCQ-P and the NCSRSQ. Taken in conjunction with other
tests of the PCQ-P's properties, this provides support for
the validity of the PCQ-P as a measure of patient experi-
ence of prostate cancer care. The findings of this study
confirm that the PCQ-P is suitable for use in service
improvement programmes. The study also highlights the
approach to using the questionnaire preferred by patients
(sections of the questionnaire administered separately, as
soon as possible after the corresponding care stage), and
indicates important considerations for hospitals planning
to use the questionnaire, including ensuring that staff
time is made available to administer the questionnaire.
The development of a version of the questionnaire that
could be self-administered via computer would be valua-
ble in addressing this problem.
Attempts to develop and improve services should include
assessment of patient experience when evaluating the
impact of changes. In the UK, the greater involvement of
commissioners in the future will present an additional
opportunity to monitor and improve patient experience,
and patient experience surveys should play a role in this
[20]. The PCQ-P could be used in future national patient
surveys. The use of a robust and acceptable questionnaire,
specifically designed to collect experiences of prostate can-
cer care, would allow GPs and hospitals to evaluate their
performance on the aspects of care that are most impor-
tant to prostate cancer patients, and to compare their per-
formance to other, similar GP practices and hospitals. The
establishment of benchmark scores for the questionnaire
would be of value in this context, and could be estab-
lished via a national survey.
Conclusion
This study has demonstrated how a sophisticated patient
experience questionnaire can be developed and evaluated
systematically. Although the development process is pro-
longed, thoroughness in development and testing pro-
vides confidence in the data produced by the measure,
and increases the value of the data for use in service eval-
uation and research. The PCQ-P could provide a starting
point for the development of instruments for other cancer
groups, as many of the issues that it covers are relevant to
other cancers. For example, the need for information and
support throughout care is pertinent to the other common
cancers, including lung, colorectal, and breast cancer. New
measures would require careful testing before use. None-
theless, the detailed process undertaken to develop the
prostate care questionnaire provides a springboard for
developing instruments for other cancers.
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